🇺🇸 FDA

Intelligence Platform

Patents

Browse 124 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9962370

Methods of treatment associated with the granulocyte colony-stimulating factor receptor

Ligand Pharmaceuticals Incorporated · Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9676809

Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675583

Selective androgen receptor modulators (SARMS) and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9662312

Method for treating glomerulosclerosis

Ligand Pharmaceuticals Incorporated · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9622991

Hematopoietic growth factor mimetic small molecule compounds and their uses

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9492430

Methods and compositions associated with the granulocyte colony-stimulating factor recepto

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9359285

Androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9326991

Nucleotide prodrug compounds and use

Ligand Pharmaceuticals Incorporated · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9266874

Heterocycle amines and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9144557

Hematopoietic growth factor mimetic small molecule compounds and their uses

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9139520

Selective androgen receptor modulators (SARMs) and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865918

Androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822467

Biaryl oxyacetic acid compounds

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748633

Selective androgen receptor modulators (SARMs) and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680150

Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic g

Ligand Pharmaceuticals Incorporated · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580811

Androgen receptor modulator methods

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8519158

Androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8354446

Selective androgen receptor modulators (SARMs) and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8193357

Androgen receptor modulator compounds

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919248

Methods for the modulation of IL-13

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7816372

6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7727980

Tricyclic androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7696246

Bicyclic androgen and progesterone receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691895

Thrombopoietin activity modulating compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted